SciDEX — THERAPEUTIC

Understanding Entity Pages

This page aggregates everything SciDEX knows about THERAPEUTIC_TARGET: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Wiki Pages (20)

Pathway Diagram

graph TD
    THERAPEUTIC_TARGET["THERAPEUTIC_TARGET"]
    IDH2["IDH2"] -->|"target for"| THERAPEUTIC_TARGET
    MTOR["MTOR"] -->|"target for"| THERAPEUTIC_TARGET
    AQP4["AQP4"] -->|"target for"| THERAPEUTIC_TARGET
    TGM2["TGM2"] -->|"target for"| THERAPEUTIC_TARGET
    P2RX1["P2RX1"] -->|"target for"| THERAPEUTIC_TARGET
    P2RX4["P2RX4"] -->|"target for"| THERAPEUTIC_TARGET
    P2RX7["P2RX7"] -->|"target for"| THERAPEUTIC_TARGET
    P2RY1["P2RY1"] -->|"target for"| THERAPEUTIC_TARGET

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (40)

Source	Relation	Type	Str
IDH2	therapeutic_target	entity	0.95
MTOR	therapeutic_target	entity	0.90
AQP4	therapeutic_target	entity	0.90
TGM2	therapeutic_target	entity	0.90
P2RX1	therapeutic_target	entity	0.90
P2RX4	therapeutic_target	entity	0.90
P2RX7	therapeutic_target	entity	0.90
P2RY1	therapeutic_target	entity	0.90
P2RY11	therapeutic_target	entity	0.90
P2RY14	therapeutic_target	entity	0.90
SOAT1	therapeutic_target	entity	0.90
PPARG	associated_with	entity	0.85
SLC16A1	therapeutic_target	entity	0.85
PRMT1	associated_with	entity	0.85
HSPA5	therapeutic_target	entity	0.80
FCGRT	therapeutic_target	entity	0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic T	0.548	neurodegeneration	Does clusterin exacerbate or protect aga

Hypothesis

Score

Disease

Analysis

CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic T

0.548

neurodegeneration

Does clusterin exacerbate or protect aga

Mentioning Analyses (30)

Scientific analyses that reference this entity

What determines the GPX4/ACSL4 balance that switches microglia from protective t

immunology | 2026-04-15 | 0 hypotheses

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.544

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.548

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

neurodegeneration | 2026-04-14 | 0 hypotheses

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596

Title & PMID	Authors	Journal	Year	Citations
No papers found

Title & PMID

Authors

Journal

Year

Citations

No papers found

Name	THERAPEUTIC_TARGET
Linked Hypotheses	1 hypotheses

THERAPEUTIC_TARGET

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

Atypical Parkinsonism

Parthanatos in Neurodegeneration

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome

PD Combination Therapy Matrix

Alzheimer's Disease Mechanism Index

Corticobasal Degeneration (CBD)

nhp-validation-animal-model

nimodipine-als

Neuroresilience Mechanisms and Evidence

Pathway Diagram

Outgoing (0)

Incoming (40)

Targeting Hypotheses (1)

Mentioning Analyses (30)

What determines the GPX4/ACSL4 balance that switches microglia from protective t

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

What signals trigger microglia to specifically recognize and phagocytose LC axon

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

What molecular mechanisms explain how KCNJ2 inhibition mitigates TBI-induced neu

What molecular mechanisms drive neuron-to-glioma synapse formation in high-neura

Why does PGC-1α overexpression paradoxically increase MPTP toxicity despite enha

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodege

How can functional hyperconnectivity patterns distinguish compensatory mechanism

What is the relative contribution of connexin-43 gap junctions vs tunneling nano

Do β-amyloid plaques and neurofibrillary tangles cause or result from cholinergi

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

What are the molecular determinants that control directional mitochondrial trans

Which specific aging-related gene expression changes in mouse brain predict huma

What are the optimal timing windows for TREM2 agonism vs antagonism across disea

Do tau aggregates represent protective responses or primary pathogenic drivers i

Which neural cell types exhibit the most pronounced gene expression alterations

Which cell-type vulnerability signatures from SEA-AD single-cell data represent

Can pathological vs physiological C1q tagging be distinguished at the molecular

What distinguishes truly senescent brain cells from merely dysfunctional reactiv

Do circadian disruptions cause neurodegeneration or result from it?

Which specific metabolic pathways in APOE4 microglia are causally linked to dysf

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

Why do clinical manifestations overlap despite distinct underlying etiologies in

Which specific metabolic pathways in APOE4+ microglia are most therapeutically t

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

What determines organelle-specific autophagy selectivity in neurodegenerative di

Related Papers (0)